Erica Browne to Young Adult
This is a "connection" page, showing publications Erica Browne has written about Young Adult.
Connection Strength
1.515
-
Incorporating end-users' voices into the development of an implant for HIV prevention: a discrete choice experiment in South Africa and Zimbabwe. BMC Womens Health. 2023 02 10; 23(1):58.
Score: 0.183
-
Efficacy is Not Everything: Eliciting Women's Preferences for a Vaginal HIV Prevention Product Using a Discrete-Choice Experiment. AIDS Behav. 2020 May; 24(5):1443-1451.
Score: 0.151
-
A Bayesian Analysis of a Randomized Clinical Trial Comparing Antimetabolite Therapies for Non-Infectious Uveitis. Ophthalmic Epidemiol. 2017 02; 24(1):63-70.
Score: 0.119
-
Higher Acceptability of the Monthly Dapivirine Ring Versus Daily Oral Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women in Sub-Saharan Africa in the REACH Trial. J Acquir Immune Defic Syndr. 2025 Dec 15; 100(5):415-424.
Score: 0.055
-
Measuring Pre-Exposure Prophylaxis (PrEP) Stigma Among Adolescent Girls and Young Women in Western Kenya: Scale Development, Validation, and Associations with PrEP Adherence. AIDS Patient Care STDS. 2025 Aug; 39(8):323-338.
Score: 0.054
-
Longer-acting preexposure prophylaxis product and delivery preferences among U.S. populations disproportionately affected by HIV: a discrete choice experiment. AIDS. 2025 Aug 01; 39(10):1364-1374.
Score: 0.053
-
PrEP knowledge, attitudes, and perceived barriers to access among American Indian/Alaska Native people in the US: Results from an online survey. PLoS One. 2025; 20(4):e0321422.
Score: 0.053
-
Greater Improvements in Vaccination Outcomes Among Black Young Adults With Vaccine-Resistant Attitudes in the United States South Following a Digital Health Intervention: Latent Profile Analysis of a Randomized Control Trial. JMIR Public Health Surveill. 2025 Apr 16; 11:e67370.
Score: 0.053
-
Evaluation of the Tu'Washindi Na PrEP Intervention to Reduce Gender-Based Violence and Increase Preexposure Prophylaxis Uptake and Adherence Among Kenyan Adolescent Girls and Young Women: Protocol for a Cluster Randomized Controlled Trial. JMIR Res Protoc. 2025 Apr 01; 14:e55931.
Score: 0.053
-
Effectiveness of an empowerment-based self-defense program among South African girls: results from a cluster-randomized control trial in schools. BMC Womens Health. 2025 Mar 14; 25(1):119.
Score: 0.053
-
Ecological momentary assessment study of same-hour polysubstance use among people who use opioids and additional substances. Drug Alcohol Depend. 2025 Apr 01; 269:112582.
Score: 0.052
-
Criminal legal system engagement among people who use drugs in Oregon following decriminalization of drug possession. Drug Alcohol Depend. 2024 Nov 01; 264:112449.
Score: 0.051
-
We choose: Adolescent girls and young women's choice for an HIV prevention product in a cross-over randomized clinical trial conducted in South Africa, Uganda, and Zimbabwe. PLoS One. 2024; 19(8):e0308577.
Score: 0.051
-
Correlates of Adherence to Oral and Vaginal Pre-exposure Prophylaxis (PrEP) Among Adolescent Girls and Young Women (AGYW) Participating in the MTN-034/REACH Trial. AIDS Behav. 2024 Sep; 28(9):2990-3000.
Score: 0.050
-
Breaking down relationship barriers to increase PrEP uptake and adherence among adolescent girls and young women in Kenya: safety and preliminary effectiveness results from a pilot cluster-randomized trial. J Int AIDS Soc. 2023 12; 26(12):e26198.
Score: 0.048
-
Using narratives to inform the development of a digital health intervention related to COVID-19 vaccination in Black young adults in Georgia, North Carolina and Alabama. Vaccine. 2022 11 15; 40(48):6908-6916.
Score: 0.045
-
The Role of Families in Adolescent and Young Adults' PrEP Use. AIDS Behav. 2022 May; 26(5):1618-1632.
Score: 0.042
-
Long-Acting Injection and Implant Preferences and Trade-Offs for HIV Prevention Among South African Male Youth. J Acquir Immune Defic Syndr. 2021 07 01; 87(3):928-936.
Score: 0.041
-
Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment. J Int AIDS Soc. 2020 06; 23(6):e25528.
Score: 0.038
-
Hygiene, Blood Flow, and Vaginal Overload: Why Women Removed an HIV Prevention Vaginal Ring During Menstruation in Malawi, South Africa, Uganda and Zimbabwe. AIDS Behav. 2020 Feb; 24(2):617-628.
Score: 0.037
-
Insights for Implementation Science From 2 Multiphased Studies With End-Users of Potential Multipurpose Prevention Technology and HIV Prevention Products. J Acquir Immune Defic Syndr. 2019 12; 82 Suppl 3:S222-S229.
Score: 0.037
-
First Impressions Matter: How Initial Worries Influence Adherence to the Dapivirine Vaginal Ring. J Acquir Immune Defic Syndr. 2019 07 01; 81(3):304-310.
Score: 0.036
-
End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study. J Int AIDS Soc. 2019 05; 22(5):e25283.
Score: 0.035
-
Young Women's Stated Preferences for Biomedical HIV Prevention: Results of a Discrete Choice Experiment in Kenya and South Africa. J Acquir Immune Defic Syndr. 2019 04 01; 80(4):394-403.
Score: 0.035
-
Polydrug use patterns, risk behavior and unmet healthcare need in a community-based sample of women who use cocaine, heroin or methamphetamine. Addict Behav. 2018 10; 85:94-99.
Score: 0.033
-
The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention. J Int AIDS Soc. 2018 03; 21(3):e25094.
Score: 0.032
-
A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Ophthalmology. 2014 Oct; 121(10):1863-70.
Score: 0.025